Risks of Stimulant Use for Attention Deficit Hyperactivity Disorder on the Developing Brain: Primum non nocere

Thapar A Cooper M. Attention deficit hyperactivity disorder. Lancet. 2016;387:1240-1250.

Shin J Roughead EE Park B Pratt NL. Cardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder (ADHD): nationwide self-controlled case series study. BMJ. 2016;353:i2550.

Singh I Wessely S. Childhood: a suitable case for treatment? Lancet Psychiatry. 2015;2:661-666.

Storebø OJ Krogh HB Ramstad E Moreira-Maia CR . Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analysis and trial sequential analysis of randomized clinical trials. BMJ. 2015;351:h5203. doi:10:1136/bmj.h5203.

Barnett R. Case histories. Attention deficit hyperactivity disorder. Lancet. 2016;387:737.

Behrman RE , ed. Neurodevelopmental dysfunction in the school-aged child. In: Nelson Textbook of Pediatrics. 17th ed. Amsterdam, Netherlands: Elsevier Health Science; 2004:107-108.

Nelson G . School difficulties. In: Textbook of Pediatrics. 6th ed. Philadelphia, PA: W.B. Saunders;1954:1121.

Behrman RE , ed. Developmental pediatrics. In: Nelson Textbook of Pediatrics. 10th ed. Philadelphia, PA: W.B. Saunders; 1975:72-73.

Vaughan VC McKay RJ Behrman RE Nelson WE , eds. Developmental dysfunction in the school-aged child. In: Nelson Textbook of Pediatrics. 11th ed. Philadelphia, PA: W.B. Saunders; 1979:151-152.

Lerner M Wigal T. Long-term safety of stimulant medications used to treat children with ADHD. Pediatr Annals. 2008;37:37-45.

Centers for Disease Control and Prevention. http://www.cdc.gov/ncbddd/adhd/data.html.Attention-deficit/hyperactivitydisorder.Dataandstatistics. Accessed June 8, 2016.

Centers for Disease Control and Prevention. ADHD in young children. https://www.cdc.gov/vitalsigns/pdf/2016-05-vitalsigns.pdf. Accessed June 8, 2016.

Drug Enforcement Administration, Office of Public Affairs. Methylphenidate and Amphetamine Yearly Production Quota (1980-2000). Washington, DC: Department of Justice; 2001.

Bates B. Treating ADHD when stimulants don’t work. Pediatric News. May 2009, p. 22.

Express Scripts. Report: turning attention to ADHD. http://lab.express-scripts.com/lab/insights/industry-updates/report-turning-attention-to-adhd. Accessed June 20, 2016.

Barbaresi WJ Katusic SK Voigt RG. Autism: a review of the state of the science for pediatric primary health care clinicians. Arch Pediatr Adolesc Med. 2006;160:1167-1175.

Schubiner H Tzelepis A Milberger S . Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers. J Clin Psychiatry. 2000;61:244-251.

King VL Brooner RK Kidorf MS Stoller KB Mirsky AF. Attention deficit hyperactivity disorder and treatment outcome in opioid abusers entering treatment. J Nerv Ment Dis. 1999;187:487-495.

Pine DS Klein RG Lindy DC Marshall RD. Attention-deficit hyperactivity disorder and comorbid psychosis: a review and two clinical presentations. J Clin Psychiatry. 1993;54:140-145.

Gomez RL Janowsky D Zetin M Leighton H Clopton PL. Adult psychiatric diagnosis and symptoms compatible with hyperactive child syndrome: a retrospective study. J Clin Psychiatry. 1981;42:389-394.

Mosholder AD Gelperin K Hammad TA Phelan K Johann-Liang R. Hallucinations and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs in children. Pediatrics. 2009;123:611-616.

Berman SM Kuczenski R McCracken JT London ED . Potential adverse effects of amphetamine treatment on brain and behavior: a review. Mol Psychiatry. 2009;14:123-142.

Ridley RM Baker HF Owen F Cross AJ Crow TJ. Behavioral and biochemical effects of chronic amphetamine treatment in the velvet monkey. Psychopharmacology. 1982;78:245-251.

Castner SA Goldman-Rakic PS. Long-lasting psychotomimetic consequences of repeated low-dose amphetamine exposure in rhesus monkeys. Neuropsychopharmacology. 1998;21:10-28.

Bock N Gerlach M Rothenberger A. Postnatal brain development and psychotropic drugs. Effects on animals and animal models of depression and attention-deficit/hyperactivity disorder. Curr Pharm Design. 2010;16:2474-2483.

McFadden LM Carter S Matuszewich L. Juvenile exposure to methamphetamine attenuates behavioral and neurochemical responses to methamphetamine in adult rats. Behav Brain Res. 2012;229:118-122.

Pechnick R Janowsky DS Judd L. Differential effects of methylphenidate and d-amphetamine on stereotyped behavior in the rat. Psychopharmacology. 1979;65:311-315.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: Primary Care Version. Washington, DC: American Psychiatric Association; 1996.

Hall W Hando J Darke S Ross J. Psychological morbidity and route of administration among amphetamine users in Sydney, Australia. Addiction. 1996;91:81-87.

Strakowski SM Kenji WS Setters MJ Keck PE Jr. Enhanced response to repeated d-amphetamine challenge: evidence for behavioral sensitization in humans. Biol Psychiatry. 1996;40:872-880.

Lipman JJ. Psychometric profiles of violent offenders with histories of psychostimulant psychosis: a pilot study. Int J Forensic Psychol. 2004;1:82-93.

Andersen SL Navalta CP. Altering the course of neurodevelopment: a framework for understanding the enduring effects of paychoactive drugs. Int J Dev Neurosci. 2004;22:423-440.

Andersen SL. Stimulants and the developing brain. Trends Pharmacol Sci. 2005;26:237-243.

Zaragoza R . The Kefauver-Harris Amendment, the pharmaceutical industry, and the F.D.A. Med Times. 1964;92:1-7.

Sroufe LA Stewart MA. Treating problem children with stimulant drugs. New Engl J Med. 1973;289:407-413.

Bourgeois FT Kim JM Mandl KD. Premarket safety and efficacy studies for ADHD medications in children. PLoS One. 2014;9:e102249. doi:10.1371/journal.pone.0102249.

Centers for Disease Control and Prevention. DES: pharmacology, data indicating lack of efficacy for prevention of miscarriage, clinical indications, and current uses. http://www.cdc.gov/des/hcp/pharmacology/index.html. Accessed June 20, 2016.

Robison LL Mertens AC Boice JD . Study design and cohort characteristics of the Childhood Cancer Survivorship Study: a multi-institutional collaborative project. Med Pediatr Oncol. 2002;38:229-239.

Parens E Johnston J Carlson GA. Pediatric mental health care dysfunction disorder? New Engl J Med. 2010;362:1853-1855.

Goldman LS Gemel M Bezman R Slanetz PJ. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. JAMA. 1998;279:1100-1107.

Rappley MD. Attention deficit-hyperactivity disorder. N Engl J Med. 2005;352:165-173.

Brown FR Voigt RG Elksnin N. AD/HD: a neurodevelopmental perspective. Contemp Pediatr. 1996;13:25-44.

Elia J Ambrosini P Berrettini W. ADHD characteristics: I. Concurrent co-morbidity patterns in children & adolescents. Child Adolesc Psychiatry Ment Health. 2008;;2:15. doi:10.1186/1753-2000-2-15.

Spencer T Biederman J Wilens T. Attention-deficit/hyperactivity disorder and comorbidity. Pediatr Clin North Am. 1999;46:915-927.

Bradley RH. The struggle to assure equal treatment for all children with ADHD. J Dev Behav Pediatr. 2007;3:404-403.

Pastor PN Reuben CA. Attention deficit disorder and learning disability: United States, 1997-98. National Center for Health Statistics. Vital Health Stat 10. 2002;(206):1-12.

McGuinness D. When Children Don’t Learn. New York, NY: Basic Books; 1985.

Zentall SS. Behavioral comparisons of hyperactive and normally active children in natural settings. J Abnorm Child Psychol. 1980;8:93-109.

Zentall SS Zentall TR. Optimal stimulation: a model of disordered activity and performance in normal and deviant children. Psychol Bull. 1983;94:446-471.

Strohschein LA. Prevalence of methylphenidate use among Canadian children following parental divorce. CMAJ. 2007;176:1711-1714.

Fabiano GA Pelham WE Coles EK Gnagy EM Chronis-Tuscano A O’Connor BC. A meta-analysis of behavioral treatments for attention-deficit/hyperactivity disorder. Clin Psychol Rev. 2009;29:129-140.

Broderick P Benjamin AB. Caffeine and psychiatric symptoms: a review. J Okla State Med Assoc. 2004;97:538-542.

Hughes JR Hale KL. Behavioral effects of caffeine and other methylxanthines in children. Exp Clin Psychopharmacol. 1998;6:87-95.

Oner P Oner O Azik FM Cop E Munir KM. Ferritin and hyperactivity ratings in attention deficit hyperactivity disorder. Pediatr Int. 2012;54:688-692.

Konofal E Lecendreus M Arnulf S Mouren M. Iron deficiency in children with attention-deficit hyperactivity disorder. Arch Pediatr Adolesc Med. 2004;158:1113-1115.

Milano S Esposito M Foderaro G Ramelli GP Pezzoli V Manconi M. Sleep-related disorders in children with attention-deficit hyperactivity disorder: preliminary results of a full sleep assessment study. CNS Neurosci Ther. 2016;22:906-914. doi:10.1111/cns.12573.

Conner DF Steeber J McBurnett K. A review of attention-deficit/hyperactivity disorder complicated by symptoms of oppositional defiant disorder or conduct disorder. J Dev Behav Pediatr. 2010;31:427-440.

Subcommittee on Attention-Deficit/Hyperactivity Disorder, Steering Committee on Quality Improvement and Management. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2011:128:1007-1022.

Schatz NK Fabiano GA Cunningham CE . Systematic review of patients’ and parents’ preferences for ADHD treatment options and processes of care. Patient. 2015;8:483-497.

Moffitt TE Arseneault L Belsky D Dickson N . A gradient of childhood self-control predicts health, wealth, and public safety. Proc Natl Acad Sci U S A. 2011;108:2693-2698.

Weiss MD Baer S Allan BA Saran K Schibuk H. The screens culture: impact on ADHD. Atten Defic Hyp Disord. 2011;3:327-334.

Chan PA Rabinowitz T. A cross-sectional analysis of video games and attention deficit hyperactivity disorder symptoms in adolescents. Ann Gen Psychiatry. 2006;5:16.

Stern HP. A Wellness Prescription: How to Raise a Happy, Healthy Child. Little Rock, AR: H.P. Stern; 1992.

McBurnett K. Attention Deficit/Hyperactivity Disorder: A 21st Century Perspective. New York, NY: Taylor & Francis; 2007.

Sprinkle N . A pragmatic parent’s guide to behavior therapy. ADDitude. http://www.additudemag.com/adhd/article/860.html. Accessed June 21, 2016.

ADDitude Editors. None of us were trained how to be good parents. ADDitude. http://www.additudemag.com/adhd/article/1563.html. Accessed June 21, 2016.

Rabiner D . Behavioral treatment for ADHD/ADD: a general overview. http://www.helpforadd.com/add-behavioral-treatment/. Accessed June 21, 2016.

Silverstein M Hironaka LK Walter HJ . Collaborative care for children with ADHD symptoms: a randomized comparative effectiveness trial. Pediatrics. 2015;135:e858-e867.

US Food and Drug Administration. A brief overview of Risk Evaluation & Mitigation Stratgies (REMS). http://www.fda.gov/downloads/AboutFDA/Transparency/Basics/UCM328784.pdf. Accessed June 21, 2016.

Newcorn JH Ivanov I. Psychopharmacologic treatment of attention-deficit/hyperactivity disorder and disruptive behavior disorders. Pediatr Ann. 2007;36:564-574.